Merck

Drugmakers Moderna and Merck said their mRNA cancer vaccine portrayed tremendous results during a preliminary study. During the announcement on Tuesday, the drugmakers said the potential skin cancer vaccine messenger RNA was developed using the same technology behind COVID-19 preventive...

The U.S. Food and Drug Administration authorized the Merck anti-covid coronavirus pill on Thursday, just one day after it OK'd the use of Pfizer's pill for the treatment of the virus. Called molnupiravir, the pill had already been authorized for...

German pharmaceutical company Merck said on Friday that its anti-Covid pill was found to be 20% less effective in a final analysis of a clinical trial. The drug, called molnupiravir, was initially estimated to cut the risk of hospitalization and...

  A Greek-American, Dr. Nick Kartsonis is the Senior Vice President in charge of global clinical trials at Merck Research Laboratories, the company that has developed the first pill authorized to combat the coronavirus. Merck pharmaceuticals developed the first antiviral pill...

Molnupiravir, the world's first anti-Covid pill to treat those who are already suffering with the infection, received approval from UK medical authorities on Thursday. The oral drug is the first pill developed to fight the virus for which the clinical...

The pharmaceuticals firm Merck asked the US Food and Drug Administration on Monday to authorize its new anti-COVID pill. If authorized for emergency use or fully approved for general use, the pill would be a powerful means of fighting the...

The German pharmaceuticals firm Merck announced on Friday that trials indicate it has produced the first effective antiviral pill to fight Covid-19. Its drug, called molnupiravir, will be placed before the authorities for authorization after clinical trials showed that it...

Pfizer announced on Monday that they are testing an oral antiviral drug that could stop coronavirus infection after exposure. The announcement comes at a time when scientists and researchers across the world are broadening their range of treatments against...

As Greece prepares to give its banks 50 billion euros ($64.6 billion) and pay some eight billion euros ($10.34 billion) in back bills to creditors, the country’s hospitals are suffering dire shortages of critical equipment, including gloves and gowns,...

German pharmaceuticals firm Merck KGaA is no longer delivering cancer drug Erbitux to Greek hospitals, a spokesman said on Saturday, the latest sign of how an economic and budget crisis is hurting frontline public services. Drugmakers raised concerns with EU...